Urinary protein excretion and serum tumor necrosis factor in diabetic patients with advanced renal failure: Effects of pentoxifylline administration

This publication has 37 references indexed in Scilit:

• Pentoxifylline Maintains Hepatocellular Function and Improves Cardiac Performance during Early Sepsis
  The Journal of Trauma: Injury, Infection, and Critical Care, 1997
• Influence of pentoxifylline on cytokine levels and inflammatory parameters in septic shock
  Intensive Care Medicine, 1996
• Effects of pentoxifylline on circulating cytokine concentrations and hemodynamics in patients with septic shock
  Critical Care Medicine, 1996
• Pentoxifylline in Management of Proteinuria in Diabetic Nephropathy
  Nephron, 1993
• Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway.
  The Journal of Experimental Medicine, 1990
• Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor α
  Kidney International, 1990
• Physiopathology and Clinical Aspects of Diabetic Nephropathy
  Nephron, 1988
• Pentoxifylline
  Drugs, 1987
• Effects of recombinant human tumor necrosis factor (rhtnf) on normal human and mouse hemopoietic progenitor cells
  The International Journal of Cell Cloning, 1987
• RANDOMISED TRIAL OF PENTOXIFYLLINE VERSUS ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE IN PREVENTING TRANSIENT ISCHAEMIC ATTACKS
  The Lancet, 1981